XML 21 R5.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF NET (LOSS) INCOME - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Dec. 30, 2023
Income Statement [Abstract]      
Net sales $ 2,386,294 $ 2,190,768 $ 2,362,657
Cost of sales 1,480,251 1,403,226 1,462,416
Gross profit 906,043 787,542 900,241
Selling, general, and administrative expenses 381,773 350,421 354,655
Research and development expenses 106,899 107,773 102,429
Amortization of intangibles 59,793 62,127 65,794
Restructuring, impairment, and other charges 320,050 108,441 16,501
Total operating expenses 868,515 628,762 539,379
Operating income 37,528 158,780 360,862
Interest expense 34,303 38,717 39,866
Foreign exchange loss (gain) (16,612) 9,230 (12,299)
Other income, net (16,994) (22,570) (19,901)
Income before income taxes 3,607 151,863 328,598
Income taxes 75,307 51,673 69,113
Net (loss) income $ (71,700) $ 100,190 $ 259,485
(Loss) income per share:      
Basic (in dollars per share) $ (2.89) $ 4.04 $ 10.44
Diluted (in dollars per share) $ (2.89) $ 4.00 $ 10.34
Weighted average shares and equivalent shares outstanding:      
Basic (in shares) 24,817 24,821 24,854
Diluted (in shares) 24,817 25,039 25,102